IVF With Embryo Testing to Avoid Passing On an Inherited Retinal Disease
IVF With Embryo Testing at a Glance
If an inherited retinal disease runs in your family, you may be wondering whether you can have a child without passing it on. One option is IVF combined with embryo genetic testing. Preimplantation genetic testing checks embryos made through IVF, and one form, called PGT-M, looks for a specific condition that one or both parents carry.1 In plain terms, doctors create embryos in the lab, test each one for your family's known gene change, and transfer an embryo that does not carry it. It is not simple or certain, but for many families it is a real path worth understanding.
It helps to be clear from the start about the limits. Embryo testing can lower the chance of having a child with your family's inherited retinal disease, but it is not a promise of a perfectly healthy baby. Preimplantation testing cannot promise an embryo will be born free of every health condition.1 It also cannot happen without IVF, which is a demanding medical process. This page walks through how it works, who it fits, what the day-to-day looks like, and the honest risks and odds.
This is not a decision to make from a website alone. It brings together eye genetics, reproductive medicine, and your own values. A genetic counselor can help you understand your risk of passing an inherited retinal disease to your children.2 You will also work with a fertility specialist, called a reproductive endocrinologist, who runs the IVF and testing. The right next step is a referral to those specialists, who can tell you whether your specific gene change can be tested.
What IVF With Embryo Testing (PGT-M) Is
Inherited retinal diseases are conditions like retinitis pigmentosa, Stargardt disease, and Leber congenital amaurosis that are written into a person's genes. Retinitis pigmentosa is a group of inherited retinal diseases that people are born with, usually caused by gene changes passed down from parents to children.2 Because the cause is a change in a single gene, families often see the same condition appear across generations. That same single-gene cause is exactly what makes embryo testing possible.
PGT-M stands for preimplantation genetic testing for monogenic, or single-gene, conditions. PGT-M checks an embryo for a specific condition that one or both birth parents carry, and it is only available to couples pursuing IVF.1 It is not a general scan for every disease. It is a targeted test aimed at the one gene change your family is known to carry, which is why the process starts with pinning down that exact change first.
The whole approach depends on knowing precisely what you are testing for. A genetic test can identify the type of inherited retinal disease in a family by finding the gene change that causes it.2 Without an identified, confirmed gene change in a parent, there is nothing specific for the embryo test to look for. This is why genetic testing of the affected parent, and often other relatives, is the true first step, well before any IVF begins.
How the IVF and Embryo-Testing Process Works
The process begins with an IVF cycle to produce several eggs at once. In IVF, you take injectable hormone medications to mature a group of eggs, which are then collected with an ultrasound-guided needle.3 The stimulation phase usually runs about two weeks with frequent monitoring visits, and the egg collection itself is a short procedure done under sedation. Producing several eggs matters here, because testing will narrow the group down.
Next, the collected eggs are fertilized in the laboratory. Each mature egg is fertilized in the lab, often by injecting a single sperm into the egg, and the embryos are grown for about five to six days to the blastocyst stage.3 Not every egg fertilizes and not every embryo keeps growing, so the number that reaches the testing stage is smaller than the number of eggs collected. This natural drop-off is expected and is part of why several eggs are gathered.
Once embryos reach the blastocyst stage, a few cells are taken for testing. At the blastocyst stage, an embryologist removes a few cells from the outside layer of the embryo for genetic testing.1 Those cells are checked for your family's specific gene change while the embryos are frozen and stored. The outer cells that are sampled are the ones that would go on to form the placenta, not the baby itself.
When results come back, your team can identify which embryos do not carry the condition. The genetic results let the team exclude affected embryos and transfer one, or sometimes more, into the uterus through a thin catheter.1 The transfer itself is quick and usually painless, more like a routine exam than surgery. Any remaining unaffected embryos can be kept frozen for a future try or a future pregnancy.
Who Is a Good Candidate
This path is designed for people who know they carry a disease-causing gene change. Preimplantation testing is chosen by people who have a history of inheritable genetic mutations that they could pass to a child.1 If you have an inherited retinal disease yourself, or you and your partner are known carriers, and your family's exact gene change has been identified, you are the kind of candidate this is built for.
How a condition is inherited shapes how useful embryo testing may be for you. Inherited retinal diseases are passed from parents to children through changed genes, and a genetic counselor can explain your specific risk of passing one on.2 Some patterns carry a high chance of an affected child in each pregnancy, and those are often where families feel the decision most keenly. A counselor can turn your family history into a clear picture of the numbers.
Candidacy is not only about genetics; it is also about being able to go through IVF. Embryo testing can only be done as part of IVF, which requires hormone stimulation, an egg-collection procedure, and an embryo transfer.1 That means the process suits people who are prepared for the time, the visits, and the physical demands of a fertility cycle. Your fertility team will review your general and reproductive health to confirm IVF is reasonable for you.
What Happens at the Consultation
Your first stop is usually genetic counseling, not the operating room. A genetic counselor helps confirm the family gene change and explain the chance of passing the retinal disease to a child.2 They review your family tree, confirm which gene and which specific change is involved, and check that a custom embryo test can be built for it. Bring any prior genetic test results and details about affected relatives, since those speed this step up.
Next you meet the fertility specialist who will run the cycle. A fertility specialist plans the IVF cycle, including the hormone stimulation and egg collection needed to create embryos for testing.3 They assess your ovarian reserve and overall health, explain the medication schedule, and set expectations for how many eggs and embryos you might realistically get. This is the visit where the calendar and the costs become concrete.
A good consultation answers the practical questions before any medication starts. Ask how long it takes to build the custom test for your gene, what happens if no unaffected embryos result, and how many cycles you can plan for. Because preimplantation testing cannot promise a child free of every health condition, the consultation should cover its limits honestly, not only its hopes.1 Leaving with realistic expectations is as important as leaving with a schedule.
When This Is Not the Right Path, or Not Possible
The single biggest reason this cannot proceed is a missing target. PGT-M looks for a specific known gene change, so it cannot be done when the family's exact disease-causing change has not been identified.1 If genetic testing has not found the responsible change, or the result is uncertain, the embryo test has nothing precise to search for. Sorting out the genetics fully comes first, and sometimes that itself takes time and further testing.
Even when a test runs, biology does not always give a clean answer. An embryo's test result can be mosaic, meaning it contains both normal and abnormal cells, which can make the result harder to interpret.1 A gene change of uncertain meaning can also leave a result in a gray zone. These situations do not always rule the path out, but they are reasons the process is guided by specialists rather than a simple yes or no.
Some limits are not medical at all. IVF is demanding, not everyone produces unaffected embryos, and the decision touches deeply personal beliefs about embryos and family. Embryo testing adds no extra health risk to a child beyond the usual risks of IVF, but it does not remove the physical and emotional demands of the IVF process itself.1 There is no wrong answer here. Choosing not to pursue it is a valid, common decision, and other routes such as natural conception with prenatal testing, donor gametes, or adoption remain open.
Recovering From Egg Retrieval and Transfer
Most people feel back to normal within a few days of the egg-collection procedure. After egg retrieval, mild bloating, abdominal cramping, and slight tenderness are common as the ovaries settle.4 Over-the-counter pain relief and rest usually handle it, and many return to light activity the next day. Your team will tell you what level of discomfort is expected so you can tell ordinary soreness apart from a warning sign.
Recovery from the transfer itself is minimal, because it is not surgery. The embryo transfer uses a thin catheter passed through the cervix and generally needs little or no recovery time.3 Some spotting or mild cramping can occur, and your clinic will advise on activity and any medications to continue. The harder part of this phase is often the wait for a pregnancy test, which is emotional more than physical.
An IVF cycle asks a lot over several weeks, so pacing yourself matters. Keep your monitoring appointments, take medications exactly as scheduled, and speak up about pain or mood. A person on fertility medication should contact their provider promptly if they develop any symptoms of ovarian hyperstimulation, such as worsening bloating or belly pain.4 Building in support, whether a partner, friend, or counselor, is part of a healthy recovery, not an extra.
Risks, Success Rates, and a Realistic Outlook
The clearest medical risk comes from the fertility medications, not the genetic test. Ovarian hyperstimulation syndrome is an excessive response to fertility medications that can cause abdominal bloating, nausea, and swelling, and in severe cases more serious symptoms.4 Clinics now adjust medication and monitor closely to keep this uncommon, and most cycles pass without it. Knowing its signs, covered below, lets you act early if it does occur.
Honest numbers help set expectations, and they lean heavily on age. In IVF, live-birth rates per egg retrieval are about 47 in 100 for people under 35 and fall to about 11 in 100 by ages 41 to 42.3 Adding embryo testing narrows the pool further, since only unaffected embryos are transferred, so more than one cycle is sometimes needed. These are population averages, not a prediction for you, and your team can estimate your own range.
For a couple who carries a known inherited retinal disease gene, this technology offers a real, if not certain, chance to have a child who does not inherit it. Embryo testing lets a team exclude embryos that carry the family's condition, though it cannot promise a child free of every health condition.1 The calibrated view is hopeful and honest at once: many families succeed, some need several tries, and a minority do not get an unaffected embryo. Going in with that full picture protects you from both false despair and false certainty.
Warning Signs After Retrieval and Who to See
Most recovery is smooth, but a few symptoms after egg collection should prompt a call the same day. Severe warning signs of ovarian hyperstimulation include severe abdominal pain, rapid or excessive weight gain, severe nausea and vomiting, difficulty breathing, decreased urination, or a painful swollen leg or chest pain.4 If you notice these, call your fertility clinic right away or seek urgent care. Acting early keeps a treatable problem from becoming serious, so do not wait it out.
Not every symptom is an alarm, and your clinic would rather hear from you than not. Anyone taking fertility medication should contact their provider if they have any symptoms of ovarian hyperstimulation, even mild ones.4 Report worsening bloating, weight gain of more than a couple of pounds in a day, or discomfort that is getting worse rather than better. A quick phone call lets the team decide whether you need to be seen.
This journey is shared among specialists, and knowing who does what helps. A genetic counselor can help someone with an inherited retinal disease understand the chance of passing it to their children.2 Your eye doctor or ocular geneticist confirms the retinal diagnosis and gene change, the counselor explains inheritance, and the fertility specialist runs the IVF and embryo testing. Keeping all of them in the loop is how the plan stays coordinated.
Common Questions About IVF and Embryo Testing for Eye Disease
No test offers a full guarantee, and that honesty matters. Preimplantation testing lowers the chance of passing on the tested condition but cannot promise a child free of every health condition.1 It is very good at identifying embryos that carry your family's specific gene change so they are not transferred. But no pregnancy is risk-free, testing has a small error rate, and other unrelated health conditions can still occur. Think of it as strongly reducing one specific risk, not erasing all risk.
Yes, and this is the single most important starting point. A genetic test can identify the specific gene change that causes an inherited retinal disease.2 That confirmed change is exactly what an embryo test is built to look for, so it has to be identified first. If your diagnosis is clinical only, or a prior test was inconclusive, you will likely need genetic testing and counseling before IVF. Bringing affected relatives into the testing sometimes helps pin down the change that the embryo test will target.
The biopsy is designed to sample cells that do not form the baby. At the blastocyst stage, only a few cells are removed from the outer layer of the embryo, which is the part that would form the placenta.1 Handling, biopsy, freezing, and thawing carry a small chance of harming an embryo so that it does not implant, which your team accounts for. For embryos that continue, testing is not known to add health risks to the child beyond those of IVF in general.
It varies widely, and fewer than you might expect. Not every egg fertilizes and only about half of fertilized embryos reach the blastocyst stage where testing is done.3 From there, only some will be free of the family gene change. This is why doctors aim to collect several eggs and why some people do more than one cycle to bank enough unaffected embryos. Your fertility team can estimate your likely numbers from your test results.
Current evidence is reassuring on this point. There are no documented added health risks to children born after preimplantation testing beyond the usual risks of IVF to parent and child.1 The test looks at cells removed from the embryo, not the future baby's own body, and children born this way are followed like any others. As with any newer-generation technology, long-term follow-up continues, but the data so far do not show extra risk from the testing itself.
This is a real possibility to plan for emotionally and practically. Sometimes a cycle produces no embryo that is both healthy to transfer and free of the family gene change. Because IVF and embryo testing narrow the pool at each step, a cycle can end without a transferable, unaffected embryo.1 If that happens, your team may suggest another cycle, and a counselor can help you weigh other paths such as donor eggs or sperm, adoption, or prenatal testing in a natural pregnancy.
More Questions About the Process and Decision
Plan for months, not weeks, mostly because of the genetics work up front. Building a custom embryo test for your specific gene change takes time before the IVF cycle even starts. Because embryo testing requires an IVF cycle with hormone stimulation, egg collection, and a later transfer, the process spans several stages over weeks to months.3 Your clinic can give you a timeline once your genetic test is confirmed and the custom test is designed.
Coverage differs a great deal by plan and location, so this needs a direct check. Some plans cover parts of IVF or genetic testing while others cover neither, and rules vary by state and employer. This page cannot tell you your benefits. Ask your fertility clinic's financial team and your own insurer for a written estimate, and ask specifically about the IVF cycle, the embryo biopsy, and the custom genetic test as separate line items so there are no surprises.
Sometimes, and it is worth asking about. Preimplantation genetic testing can check embryos for genetic or chromosomal conditions, and a targeted PGT-M test focuses on the specific condition a parent carries.1 Some couples add testing for chromosome number at the same time. What can be combined depends on your situation and the lab, so discuss with your team which tests make sense together rather than assuming everything is bundled.
Yes. Your own eye care continues alongside the family-planning work. A person with an inherited retinal disease should stay under the care of an eye doctor or ocular geneticist for diagnosis and monitoring.2 They confirm the diagnosis and the gene change that the embryo test targets, and they manage your vision over time. Keeping that relationship active also means you hear about new treatments and research as they emerge.
- Has my family's exact disease-causing gene change been confirmed?
- Can a custom embryo test be built for my specific gene change?
- How many eggs and embryos might I realistically expect?
- What happens if no unaffected embryos result from a cycle?
- What are my personal risks from the fertility medications?
- What warning signs after egg collection should make me call you the same day?